Homocysteine and Laminin Are Not Prognostic Markers in Patients with Septic Inflammatory Response Syndrome | Zendy

Brigitte Stoiser | Zendy; Florian Thalhammer | Zendy; Ibrahim Elmenyawi | Zendy; Astrid Wilfing | Zendy; Florian Daxböck | Zendy; Gottfried J. Locker | Zendy; Heinz Burgmann | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Homocysteine and Laminin Are Not Prognostic Markers in Patients with Septic Inflammatory Response Syndrome

Author(s) -

Brigitte Stoiser,

Florian Thalhammer,

Ibrahim Elmenyawi,

Astrid Wilfing,

Florian Daxböck,

Gottfried J. Locker,

Heinz Burgmann

Publication year - 2000

Publication title -

clinical and diagnostic laboratory immunology

Language(s) - English

Resource type - Journals

eISSN - 1098-6588

pISSN - 1071-412X

DOI - 10.1128/cdli.7.1.119-121.2000

Subject(s) - homocysteine , medicine , plasma homocysteine , laminin , systemic inflammatory response syndrome , gastroenterology , inflammatory response , inflammation , sepsis , biology , biochemistry , extracellular matrix

The aim of this study was to measure plasma homocysteine and laminin concentrations in patients with nonbacteremic systemic inflammatory response syndrome (SIRS) and to compare them with those of a healthy control group. Concerning laminin, significant increased concentrations could be observed in the SIRS group compared to the control group, but for homocysteine, no significance could be observed. In summary, homocysteine and laminin levels are not useful in the prediction of a patient's outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research